secwatch / observer

8-K filed November 12, 2024, 6:59 PM ET ticker LSTA CIK 0000320017

earnings confidence high sentiment neutral materiality 0.55

Lisata Therapeutics Q3 2024 net loss $4.9M; cash runway into early 2026; multiple trial updates

LISATA THERAPEUTICS, INC.

2024-Q3 EPS reported -$1.85

Net loss of $4.9M in Q3 2024, improved from $5.3M loss in Q3 2023.
Cash, cash equivalents and marketable securities of $35.9M as of Sep 30, 2024; funds operations into early 2026.
Phase 2b ASCEND trial (mPDAC) Cohort A interim data expected at ASCO GI in Jan 2025; Cohort B data mid-2025.
BOLSTER Phase 2a first-line cholangiocarcinoma enrollment complete ahead of plan; topline data mid-2025; second-line cohort added.
Entered research collaborations for certepetide: endometriosis (Univ. of Cincinnati) and melanoma (Valo Therapeutics).

item 2.02 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0000320017-24-000057
form_type: 8-K
ticker: LSTA
cik: 0000320017
company_name: LISATA THERAPEUTICS, INC.
filed_at: 2024-11-12T23:59:59+00:00
discovered_at: 2026-05-14T18:03:10.700130+00:00
generated_at: 2026-05-30T02:25:03.130264+00:00
sec_items: ["2.02", "7.01", "9.01"]
event_type: earnings
sentiment: neutral
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0000320017-24-000057
json_url: https://secwatch.observer/filing/0000320017-24-000057.json
markdown_url: https://secwatch.observer/filing/0000320017-24-000057.md
text_url: https://secwatch.observer/filing/0000320017-24-000057.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/320017/000032001724000057/0000320017-24-000057-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/320017/000032001724000057/clbs-20241112.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

KSS

Kohl's Q1 net loss $14M; comparable sales down 1.1% YoY; affirms FY outlook

KOHLS Corp May 28, 2026, 7:00 AM ET earnings Items 2.02, 7.01, 8.01, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

BAH

Booz Allen reports Q4 revenue down 6.4% to $2.78B; adjusted EPS up 10.6% to $1.78

Booz Allen Hamilton Holding Corp May 22, 2026, 6:49 AM ET earnings Items 2.02, 7.01, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

DEERE JOHN CAPITAL CORP

John Deere Capital Q2 net income up 22% to $151M, portfolio down 3%

DEERE JOHN CAPITAL CORP May 21, 2026, 6:17 AM ET earnings Items 2.02, 7.01, 8.01, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

Deere reports Q2 FY2026 results; press release omitted from filing text

DEERE & CO May 21, 2026, 6:00 AM ET earnings Items 2.02, 7.01, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

FJET

Starfighters Space Q1 net loss widens to $4.27M on $0 revenue; cash drops to $1.40M

Starfighters Space, Inc. May 20, 2026, 9:55 PM ET earnings Items 2.02, 7.01, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

DAVEY TREE EXPERT CO

Davey Tree Q1 net loss widens to $10.7M; revenue flat at $435.8M

DAVEY TREE EXPERT CO June 1, 2026, 1:50 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

KEY

KeyCorp reports 1Q26 diluted EPS $0.44, NII up 11% YoY; targets 3.25%+ NIM by 4Q27

KEYCORP /NEW/ May 29, 2026, 5:12 PM ET earnings Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

BKE

Buckle Q1 net income $46.9M ($0.93/share), sales up 6.1% to $288.7M

BUCKLE INC May 29, 2026, 3:38 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0000320017-24-000057

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.